JMP Securities reiterated its Market Outperform rating and $7.00 price target for Esperion Therapeutics (NASDAQ:ESPR) stock, ...

JMP Securities has reaffirmed its Market Outperform rating and a price target of $41.00 on Exelixis stock (NASDAQ:EXEL), aligning with the broader analyst consensus that sees upside potential.

JMP Securities analyst Matthew Condon initiated coverage of Trade Desk (TTD) with an Outperform rating and $150 price target The firm says the ...

Investigators reportedly found that JMP Pizza Inc. allowed three children to work longer and later hours than laws permit.

JMP Securities initiated coverage of Roku (ROKU) with an Outperform rating and $95 price target The firm says the company is well positioned ...

On Tuesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $2.92 which represents a decrease of $-0.24 or -7.59% from the prior close of $3.16. The stock opened at $3.17 and ...

Federal officials said five children were involved in the violations at a Farmington Hills location on 11 Mile.

JMP Securities has downgraded Alphabet shares (GOOG, GOOGL) to Market Perform from Outperform, citing concerns over pending antitrust litigation.The firm believes the Department of Justice case ...

Benchmark believes that Roku can benefit meaningfully from establishing partnerships with other platforms and further ...

JMP Securities analyst Mitch Germain upgraded Broadstone Net Lease (BNL) to Outperform from Market Perform with a $21 price target The firm believes progress from the company’s portfolio ...

Google parent Alphabet Inc. has been downgraded to market perform from market outperform by JMP Securities, with the analyst firm highlighting the potential impact of the company’s antitrust battle.